• 1. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

Introduction to (6-Chloroimidazo1,2-apyridin-2-yl)methanol (CAS No. 1039416-36-8)

(6-Chloroimidazo1,2-apyridin-2-yl)methanol, with the CAS number 1039416-36-8, is a significant compound in the field of pharmaceutical chemistry. This heterocyclic molecule has garnered attention due to its unique structural properties and potential applications in drug development. The compound features a fused imidazo[1,2-a]pyridine core, which is a common motif in many bioactive molecules, particularly in the design of small-molecule inhibitors targeting various biological pathways.

The presence of a chloro substituent at the 6-position of the imidazo[1,2-a]pyridine ring enhances its reactivity and makes it a valuable intermediate in synthetic chemistry. The methanol moiety at the 2-position provides a hydrophilic group, which can influence the solubility and pharmacokinetic properties of derivatives derived from this compound. This balance of hydrophobic and hydrophilic elements makes (6-Chloroimidazo1,2-apyridin-2-yl)methanol a versatile building block for medicinal chemists.

In recent years, there has been growing interest in imidazo[1,2-a]pyridine derivatives due to their broad spectrum of biological activities. These compounds have been explored for their potential in treating various diseases, including cancer, inflammation, and infectious diseases. The< strong>chlorosubstituted imidazo[1,2-a]pyridines are particularly noteworthy because they can serve as scaffolds for developing kinase inhibitors, which are crucial in targeted cancer therapies.

One of the most exciting areas of research involving (6-Chloroimidazo1,2-apyridin-2-yl)methanol is its application in the development of tyrosine kinase inhibitors. Tyrosine kinases are enzymes that play a key role in cell signaling pathways and are often overactive in cancer cells. By inhibiting these kinases, it is possible to disrupt the signaling pathways that promote tumor growth and survival. Several preclinical studies have demonstrated the potential of imidazo[1,2-a]pyridine derivatives as effective tyrosine kinase inhibitors. For instance, compounds with similar structures have shown promising activity against src-family kinases, which are involved in various cellular processes including cell proliferation and survival.

The synthesis of (6-Chloroimidazo1,2-apyridin-2-yl)methanol involves multi-step organic reactions that require careful optimization to achieve high yields and purity. The chlorination step is particularly critical, as it introduces the< strong>chloro substituent that is essential for subsequent functionalization. Advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions have been employed to construct the imidazo[1,2-a]pyridine core efficiently. These methods not only improve the efficiency of the synthesis but also minimize side reactions, leading to cleaner products.

The pharmacological properties of (6-Chloroimidazo1,2-apyridin-2-yl)methanol and its derivatives have been extensively studied in vitro and in vivo. Initial pharmacokinetic studies have shown that this compound has good oral bioavailability and moderate tissue distribution. This makes it an attractive candidate for further development into an oral therapeutic agent. Additionally, preliminary toxicity studies have indicated that (6-Chloroimidazo1,2-apyridin-2-yl)methanol is well-tolerated at therapeutic doses, suggesting its potential for safe use in humans.

In conclusion, (6-Chloroimidazo1,2-apyridin-2-yl)methanol (CAS No. 1039416-36-8) is a promising compound with significant potential in pharmaceutical applications. Its unique structural features and biological activities make it a valuable tool for drug discovery and development. As research continues to uncover new therapeutic targets and mechanisms, compounds like (6-Chloroimidazo1,2-apyridin-2-yl)methanol are likely to play an increasingly important role in the fight against human disease.

• 182181-19-7(6-Chloroimidazo[1,2-a]pyridine-2-carboxylic acid)
• 173159-42-7(8-Chloro-2-methylimidazo[1,2-a]pyridine)
• 1020038-45-2(8-Chloroimidazo[1,2-a]pyridine-2-carboxylic acid)
• 1421786-55-1(7-chloro-2-(methoxymethyl)-Imidazo[1,2-a]pyridine)
• 30489-62-4(Imidazo1,2-apyridin-3-ylmethanol hydrochloride)
• 1421786-09-5(8-chloro-2-(methoxymethyl)-Imidazo[1,2-a]pyridine)
• 1284210-65-6(6-chloro-3-methyl-Imidazo[1,2-a]pyridine)
• 138642-97-4(6-Chloroimidazo[1,2-a]pyridine-3-carboxylic acid)
• 82090-52-6({imidazo[1,2-a]pyridin-2-yl}methanol)
• 13583-92-1(6-Chloro-2-Methylimidazo1,2-APyridine)